Progressive bulbar palsy (Q41048): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Paralisia bulbar progressiva (PBP) é uma variante da esclerose lateral amiotrófica que inicialmente se apresenta com sintomas de fraqueza bulbar, como disartria e disfagia. Os sintomas podem permanecer relativamente restritos à região bulbar. PBP afeta mais comumente mulheres do que homens. Os pacientes tipicamente evoluem para desenvolver fraqueza nos membros e características consistentes com ELA mais típica em um estágio mais tardio da doença.
description / endescription / en
 
Progressive bulbar palsy (PBP) is a variant of amyotrophic lateral sclerosis that initially presents with symptoms of bulbar weakness such as dysarthria and dysphagia. Symptoms may remain relatively confined to the bulbar region. PBP more commonly affects females than males. Patients typically progress to develop limb weakness and features consistent with more typical ALS at a later stage of disease.

Revision as of 07:06, 13 August 2026

Progressive bulbar palsy (PBP) is a variant of amyotrophic lateral sclerosis that initially presents with symptoms of bulbar weakness such as dysarthria and dysphagia. Symptoms may remain relatively confined to the bulbar region. PBP more commonly affects females than males. Patients typically progress to develop limb weakness and features consistent with more typical ALS at a later stage of disease.
Language Label Description Also known as
default for all languages
8B60.1
    English
    Progressive bulbar palsy
    Progressive bulbar palsy (PBP) is a variant of amyotrophic lateral sclerosis that initially presents with symptoms of bulbar weakness such as dysarthria and dysphagia. Symptoms may remain relatively confined to the bulbar region. PBP more commonly affects females than males. Patients typically progress to develop limb weakness and features consistent with more typical ALS at a later stage of disease.

      Statements